List of publications 2012

  1. Aarestrup J, Kyro C, Knudsen KE, Weiderpass E, Christensen J, Kristensen M, Wurtz AM, Johnsen NF, Overvad K, Tjonneland A& Olsen A. Plasma enterolactone and incidence of cancer in a case-cohort study of Danish women. Br J Nutr 2012;1-7.
    PubMed
  2. Agudo A, Bonet C, Travier N, Gonzalez CA, Vineis P, Bueno-de-Mesquita HB, Trichopoulos D, Boffetta P, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Lukanova A, Schutze M, Boeing H, Tjonneland A, Halkjaer J, Overvad K, Dahm CC, Quiros JR, Sanchez MJ, Larranaga N, Navarro C, Ardanaz E, Khaw KT, Wareham NJ, Key TJ, Allen NE, Trichopoulou A, Lagiou P, Palli D, Sieri S, Tumino R, Panico S, Boshuizen H, Buchner FL, Peeters PH, Borgquist S, Almquist M, Hallmans G, Johansson I, Gram IT, Lund E, Weiderpass E, Romieu I& Riboli E. Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. J Clin Oncol 2012.
    PubMed
  3. Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA& Lind GE. A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin Transl Gastroenterol 2012; 3:e27.
    PubMed
  4. Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J. Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer. Am J Epidemiol 2012; 175(7):685-695.
    PubMed
  5. Austvoll-Dahlgren A, Falk RS,Helseth S. Cognitive factors predicting intentions to search for health information: an application of the theory of planned behaviour. Health Info Libr J 2012; 29(4):296-308.
    PubMed
  6. Bakken IJ, Gystad SO, Christensen OO, Huse UE, Laronningen S, Nygard J, Holmstrom L, Johannesen TB, Moller B, Larsen IK. Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway. Tidsskr Nor Laegeforen 2012; 132(11):1336-1340.
    PubMed
  7. Baste V, Moen BE, Oftedal G, Strand LA, Bjorge L, Mild KH. Pregnancy Outcomes After Paternal Radiofrequency Field Exposure Aboard Fast Patrol Boats. J Occup Environ Med 2012.
    PubMed
  8. Berstad P, Thiis-Evensen E, Vatn MH& Almendingen K. Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients. Journal of Oncology 2012.
    PubMed
  9. Borch KB, Braaten T, Lund E& Weiderpass E. Physical activity and mortality among Norwegian women - the Norwegian Women and Cancer Study. Clinical Epidemiology 2012; 3(1):229-235.
    Dovepress
  10. Borena W, Strohmaier S, Lukanova A, Bjorge T, Lindkvist B, Hallmans G, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Haggstrom C, Tretli S, Concin H, Jonsson H, Stattin P, Ulmer H. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 2012; 131(1):193-200.
    PubMed 
  11. Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ. Antidepressants to cancer patients during the last year of life-a population-based study. Psychooncology 2012.
    PubMed
  12. Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, Mangone L, Francisci S. Progress in colorectal cancer survival in Europe, from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2012.
    PubMed 
  13. Bretthauer M, Hoff G. Comparative effectiveness research in cancer screening programmes. BMJ 2012; 344:e2864.
    PubMed
  14. Bugge MD, Kjaerheim K, Foreland S, Eduard W, Kjuus H. Lung cancer incidence among Norwegian silicon carbide industry workers: associations with particulate exposure factors. Occup Environ Med 2012.
    PubMed
  15. Canchola AJ, Anton-Culver H, Bernstein L, Clarke CA, Henderson K, Ma H, Ursin G, Horn-Ross PL. Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control 2012; 23(3):473-485.
    PubMed
  16. Chepovetsky J, Kalir T, Weiderpass E. Clinical Applicability of Microarray Technology in the Diagnosis, Prognostic Stratification, Treatment and Clinical Surveillance of Cervical Adenocarcinoma. Curr Pharm Des 2012.
    PubMed
  17. Christensen JS, Mortensen LH, Roosli M, Feychting M, Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Aydin D, Kuehni CE, Prochazka M, Lannering B, Klaeboe L, Eggen T, Schuz J. Brain tumors in children and adolescents and exposure to animals and farm life: a multicenter case-control study (CEFALO). Cancer Causes Control 2012.
    PubMed
  18. Chuang SC, Jenab M, Heck JE, Bosetti C, Talamini R, Matsuo K, Castellsague X, Franceschi S, Herrero R, Winn DM, La VC, Morgenstern H, Zhang ZF, Levi F, Dal ML, Kelsey K, McClean MD, Vaughan T, Lazarus P, Muscat J, Ramroth H, Chen C, Schwartz SM, Eluf-Neto J, Hayes RB, Purdue M, Boccia S, Cadoni G, Zaridze D, Koifman S, Curado MP, Ahrens W, Benhamou S, Matos E, Lagiou P, Szeszenia-Dabrowska N, Olshan AF, Fernandez L, Menezes A, Agudo A, Daudt AW, Merletti F, Macfarlane GJ, Kjaerheim K, Mates D, Holcatova I, Schantz S, Yu GP, Simonato L, Brenner H et al. Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium. Cancer Causes Control 2012; 23(1):69-88.
    PubMed
  19. Conroy SM, Koga K, Woolcott CG, Dahl T, Byrne C, Nagata C, Ursin G, Yaffe MJ, Vachon CM, Maskarinec G. Higher alcohol intake may modify the association between mammographic density and breast cancer: An analysis of three case-control studies. Cancer Epidemiol 2012.
    PubMed
  20. Couto E, Qureshi SA, Hofvind S, Hilsen M, Aase H, Skaane P, Vatten L, Ursin G. Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 2012; 132(1):297-305.
    PubMed
  21. Cvancarova M, Aagnes B, Fossa SD, Lambert PC, Moller B, Bray F. Proportion cured models applied to 23 cancer sites in norway. Int J Cancer 2012.
    PubMed
  22. Deltour I, Auvinen A, Feychting M, Johansen C, Klaeboe L, Sankila R, Schuz J. Mobile Phone Use and Incidence of Glioma in the Nordic Countries 1979-2008: Consistency Check. Epidemiology 2012; 23(2):301-307.
    PubMed
  23. Duan L, Xu X, Koebnick C, Lacey JV, Jr., Sullivan-Halley J, Templeman C, Marshall SF, Neuhausen SL, Ursin G, Bernstein L, Henderson KD. Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril 2012; 97(1):111-117.
    PubMed
  24. Edgren G, Adami HO, Weiderpass VE, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2012.
    PubMed
  25. Edlinger M, Strohmaier S, Jonsson H, Bjorge T, Manjer J, Borena WT, Haggstrom C, Engeland A, Tretli S, Concin H, Nagel G, Selmer R, Johansen D, Stocks T, Hallmans G, Stattin P, Ulmer H. Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study. J Hypertens 2012; 30(2):290-296.
    PubMed
  26. Ellingjord-Dale M, Lee E, Couto E, Ozhand A, Qureshi SA, Hofvind S, Van Den Berg DJ, Akslen LA, Grotmol T, Ursin G. Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users. Breast Cancer Res 2012; 14(5):R135.
    PubMed
  27. Enerly E, Bray F, Mellem C, Hansen BT, Kjolberg G, Dahl T, Johannesen TB, Nygard M. Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway. Acta Oncol 2012; 51(1):45-50.
    PubMed
  28. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication. European Colorectal Cancer Screening Guidelines Working Group (G. Hoff). Endoscopy 2012; 45(1):51-59.
    Doi
  29. Fedirko V, Jenab M, Rinaldi S, Biessy C, Allen NE, Dossus L, Onland-Moret NC, Schutze M, Tjonneland A, Hansen L, Overvad K, Clavel-Chapelon F, Chabbert-Buffet N, Kaaks R, Lukanova A, Bergmann MM, Boeing H, Trichopoulou A, Oustoglou E, Barbitsioti A, Saieva C, Tagliabue G, Galasso R, Tumino R, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Gram IT, Sanchez S, Duell EJ, Molina-Montes E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Lundin E, Idahl A, Khaw KT, Romaguera-Bosch D, Wark PA, Norat T& Romieu I. Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Ann Epidemiol 2012; 23(2):93-98.
    PubMed
  30. Fedirko V, Lukanova A, Bamia C, Trichopolou A, Trepo E, Nothlings U, Schlesinger S, Aleksandrova K, Boffetta P, Tjonneland A, Johnsen NF, Overvad K, Fagherazzi G, Racine A, Boutron-Ruault MC, Grote V, Kaaks R, Boeing H, Naska A, Adarakis G, Valanou E, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Weiderpass E, Skeie G, Engeset D, Quiros JR, Zamora-Ros R, Sanchez MJ, Amiano P, Huerta JM, Barricarte A, Johansen D, Lindkvist B, Sund M, Werner M, Crowe F, Khaw KT, Ferrari P, Romieu I, Chuang SC, Riboli E& Jenab M. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol 2012.
    PubMed
  31. Ferrari P, McKay JD, Jenab M, Brennan P, Canzian F, Vogel U, Tjonneland A, Overvad K, Tolstrup JS, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Boeing H, Bergmann M, Trichopoulou A, Katsoulis M, Trichopoulos D, Krogh V, Panico S, Sacerdote C, Palli D, Tumino R, Peeters PH, van Gils CH, Bueno-de-Mesquita B, Vrieling A, Lund E, Hjartaker A, Agudo A, Suarez LR, Arriola L, Chirlaque MD, Ardanaz E, Sanchez MJ, Manjer J, Lindkvist B, Hallmans G, Palmqvist R, Allen N, Key T, Khaw KT, Slimani N, Rinaldi S, Romieu I, Boffetta P, Romaguera D, Norat T, Riboli E. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr 2012.
    PubMed
  32. Froberg M, Norman I, Johansson B, Hjerpe A, Weiderpass E, Andersson S. Liquid-Based Cytology with HPV Triage of Low-Grade Cytological Abnormalities versus Conventional Cytology in Cervical Cancer Screening. Curr Pharm Des 2012.
    PubMed
  33. Garborg KK, Loberg M, Matre J, Holme O, Kalager M, Hoff G, Bretthauer M. Reduced pain during screening colonoscopy with an ultrathin colonoscope: a randomized controlled trial. Endoscopy 2012.
    PubMed
  34. Garwicz S, Anderson H, Olsen JH, Falck WJ, Sankila R, Langmark F, Tryggvadottir L, Moller TR. Late and very late mortality in 5-year survivors of childhood cancer: Changing pattern over four decades. Experience from the Nordic countries. Int J Cancer 2012.
    PubMed
  35. Ghaderi S, Lie RT, Moster D, Ruud E, Syse A, Wesenberg F, Bjorge T. Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway. Cancer Causes Control 2012; 23(9):1297-1305.
    PubMed
  36. Giordano L, von KL, Tomatis M, Majek O, de WC, Lancucki L, Hofvind S, Nystrom L, Segnan N, Ponti A, Van HG, Martens P, Majek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Pentek Z, Budai A, Madai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de CJ, Natal C, Prieto M, Sanchez-Contador EC, Zubizarreta AR, Fernandez Llanes SB, Ascunce N, Ederra SM, Sarriugarte IG, Salas TD, Ibanez CJ, Wiege M, Ohlsson G, Tornberg S, Korzeniewska M, de WC, Fracheboud J, Patnick JJ, Lancucki L et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen 2012; 19 Suppl 1:72-82.
    PubMed
  37. Gislefoss RE, Grimsrud TK, Hoie K, Morkrid L. Stability of testosterone measured in male archival serum samples by two different methods. Scand J Clin Lab Invest 2012.
    PubMed
  38. Glattre E, Nygard JF, Aaseth J. Selenium and cancer prevention: Observations and complexity. J Trace Elem Med Biol 2012; 26(2-3):168-169.
    PubMed
  39. Grimsrud TK, Andersen A. Unrecognized risks of nickel-related respiratory cancer among Canadian electrolysis workers. Scand J Work Environ Health 2012.
    PubMed
  40. Gulati S, Jakola AS, Johannesen TB, Solheim O. Survival and Treatment Patterns of Glioblastoma in the Elderly: A Population-based Study. World Neurosurg 2012.
    PubMed
  41. Haggstrom C, Stocks T, Ulmert D, Bjorge T, Ulmer H, Hallmans G, Manjer J, Engeland E, Nagel, G, Almquist M, Selmer, R, Concin, h, Tretli S, Jonsson H, Stattin, P.  Prospective study on metabolic factors and risk of prostate cancer. Cancer 2012. PubMed
  42. Hansen BT, Nygard M, Falk RS, Hofvind S. Breast cancer and ductal carcinoma in situ among women with prior squamous or glandular precancer in the cervix: a register-based study. Br J Cancer 2012.
    PubMed
  43. Hassan BA, Yusoff ZB, Hassali MA, Othman SB& Weiderpass E. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients. Asian Pac J Cancer Prev 2012; 13(9):4373-4378.
    PubMed
  44. Hauge IH, Pedersen K, Sanderud A, Hofvind S, Olerud HM. Patient doses from screen-film and full-film digital mammography in a populatian based screening-program. Radiat Prot Dosimetry 2012; 148(1):65-73.
    PubMed
  45. Hoff G, Moritz V, Bretthauer M, Aabakken L, Berset IP, Glomsaker T, Hoie O, de LT. Incontinence after colonoscopy - an unrecognized and preventable problem. A cross-sectional study from the Gastronet quality assurance program. Endoscopy 2012; 44(4):349-353.
    PubMed
  46. Hoff SR, Abrahamsen AL, Samset JH, Vigeland E, Klepp O, Hofvind S. Breast Cancer: Missed Interval and Screening-detected Cancer at Full-Field Digital Mammography and Screen-Film Mammography-- Results from a Retrospective Review. Radiology 2012.
    PubMed
  47. Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S. Breast cancer incidence trends in Norway - explained by hormone therapy or mammographic screening? Int J Cancer 2012; 130(12):2930-2938.
    PubMed
  48. Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Tornberg S, Van HG, Martens P, Majek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Pentek Z, Budai A, Madai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de CJ, Natal C, Prieto M, Sanchez-Contador EC, Zubizarreta AR, Fernandez Llanes SB, Ascunce N, Ederra SM, Sarriugarte IG, Salas TD, Ibanez CJ, Wiege M, Ohlsson G, Tornberg S, Korzeniewska M, de WC, Fracheboud J, Patnick J, Lancucki L, Ducarroz S et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen 2012; 19 Suppl 1:57-66.
    PubMed
  49. Hofvind S, Geller BM, Skelly J& Vacek PM. Sensitivity and specificity of mammographic screening as practiced in Vermont and Norway. Br J Radiol 2012.
    Doi:10.1259/bjr/15168178
  50. Hofvind S, Skaane P. Stage Distribution of Breast Cancer Diagnosed Before and After Implementation of Population-Based Mammographic Screening. Rofo 2012.
    PubMed
  51. Hofvind S, Lee CI, Elmore JG. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat 2012.
    PubMed
  52. Holmberg L, Robinson D, Sandin F, Bray F, Linklater KM, Klint A, Lambert PC, Adolfsson J, Hamdy FC, Catto J, Moller H. A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study. Cancer Epidemiol 2012; 36(1):e7-12.
    PubMed
  53. Horn-Ross PL, Canchola AJ, Bernstein L, Clarke CA, Lacey JV, Neuhausen SL, Reynolds P, Ursin G. Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2012.
    PubMed
  54. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, Morkrid L, Gislefoss R, Ueland PM. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012; 58(2):402-410.
    PubMed
  55. Johansson M, Roberts A, Chen D, Li Y, Delahaye-Sourdeix M, Aswani N, Greenwood MA, Benhamou S, Lagiou P, Holcatova I, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Barzan L, Canova C, Thakker NS, Conway DI, Znaor A, Healy CM, Ahrens W, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Fabianova E, Mates IN, Bencko V, Foretova L, Janout V, Curado MP, Koifman S, Menezes A, Wunsch-Filho V, Eluf-Neto J, Boffetta P, Franceschi S, Herrero R, Fernandez GL, Talamini R, Boccia S, Galan P, Vatten L, Thomson P, Zelenika D, Lathrop M, Byrnes G, Cunningham H, Brennan P, Wakefield J et al. Using Prior Information from the Medical Literature in GWAS of Oral Cancer Identifies Novel Susceptibility Variant on Chromosome 4 - the AdAPT Method. PLoS One 2012; 7(5):e36888.
    PubMed
  56. Johnsen SJ, Brun JG, Goransson LG, Smastuen MC, Johannesen TB, Haldorsen K, Harboe E, Jonsson R, Meyer PA& Omdal R. The risk of non-hodgkin lymphoma in primary sjogren's syndrome, a population-based study. Arthritis Care Res (Hoboken ) 2012.
    PubMed
  57. Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van BM, Regula J, van LM, Stefansson T, Pahlman L, Dekker E, Hernan MA, Garborg K, Hoff G. The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012; 44(7):695-702.
    PubMed
  58. Klungsoyr O, Sexton J, Sandanger I, Nygard JF. A time-varying measurement error model for age of onset of a psychiatric diagnosis: Applied to first depressive episode diagnosed by the Composite International Diagnostic Interview (CIDI). Journal of Applied Statistics. In press
  59. Koivisto-Korander R, Scelo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E. Second primary malignancies among women with uterine sarcoma. Gynecol Oncol 2012; 126(1):30-35.
    PubMed
  60. Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: Results from NORDCAN and NOCCA databases. Maturitas 2012.
    PubMed
  61. Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fossa SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Hum Reprod 2012; 27(5):1525-1535.
    PubMed
  62. Kvammen O, Tretli S, Johannesen TB, Klepp O, Grotmol T. Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958-2007. Acta Oncol 2012; 51(2):177-184. Doi:10.3109/0284186X.2011.642307
  63. Laake I, Carlsen MH, Pedersen JI, Weiderpass E, Selmer R, Kirkhus B, Thune I, Veierod MB. Intake of trans fatty acids from partially hydrogenated vegetable and fish oils and ruminant fat in relation to cancer risk. Int J Cancer 2012.
    PubMed
  64. Lagiou P, Sandin S, Lof M, Trichopoulos D, Adami HO, Weiderpass E. Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ 2012; 344:e4026. Doi:10.1136/bmj.e4026
  65. Langseth H, Gislefoss R, Martinsen JI, Tretli S. Scientific scope of integrating research activities in the Janus Serum Bank. Nor J Epidemiol 2012; 21(2):185-190.
    Norwegian Journal of Epidemiology
  66. Laugsand TS, Kaasa S, Romundstad P, Johannesen TB& Lund JA. Radiotherapy for bone metastases: Practice in Norway 1997-2007. A national registry-based study. Acta Oncol 2012.
    PubMed
  67. Lee E, Ingles SA, Van Den Berg D, Wang W, Lavallee C, Huang MH, Crandall CJ, Stanczyk FZ, Greendale GA, Ursin G. Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Menopause 2012; 19(3):302-310.
    PubMed
  68. Lee E, Hsu C, Van Den Berg D, Ursin G, Koh WP, Yuan JM, Stram DO, Yu MC, Wu AH. Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 2012.
    PubMed
  69. Lindkvist B, Almquist M, Bjorge T, Stocks T, Borena W, Johansen D, Hallmans G, Engeland A, Nagel G, Jonsson H, Selmer R, Diem G, Haggstrom C, Tretli S, Stattin P& Manjer J. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control 2012.
    PubMed
  70. Lof M, Bergstrom K, Weiderpass E. Physical activity and biomarkers in breast cancer survivors: A systematic review. Maturitas 2012.
    PubMed
  71. Macfarlane TV, Macfarlane GJ, Thakker NS, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H, Lagiou P, Lagiou A, Castellsague X, Agudo A, Slamova A, Plzak J, Merletti F, Richiardi L, Talamini R, Barzan L, Kjaerheim K, Canova C, Simonato L, Conway DI, McKinney PA, Thomson P, Sloan P, Znaor A, Healy CM, McCartan BE, Marron M, Brennan P. Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. Ann Oncol 2012; 23(4):1053-1060.
    PubMed
  72. Mahabir S, Aagaard K, Anderson LM, Herceg Z, Hiatt RA, Hoover RN, Linet MS, Medina D, Potischman N, Tretli S, Trichopoulos D, Troisi R. Challenges and opportunities in research on early-life events/exposures and cancer development later in life. Cancer Causes Control 2012.
    PubMed
  73. Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R. Oral contraceptive formulation and risk of breast cancer. Contraception 2012; 85(4):342-350.
    PubMed
  74. Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B. Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol 2012.
    PubMed
  75. Marron M, Boffetta P, Moller H, Ahrens W, Pohlabeln H, Benhamou S, Bouchardy C, Lagiou P, Lagiou A, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Macfarlane GJ, Talamini R, Barzan L, Canova C, Simonato L, Biggs AM, Thomson P, Conway DI, McKinney PA, Znaor A, Healy CM, McCartan BE, Brennan P, Hashibe M. Risk of upper aerodigestive tract cancer and type of alcoholic beverage: a European multicenter case-control study. Eur J Epidemiol 2012.
    PubMed
  76. Meyer HE, Robsahm TE, Bjorge T, Brustad M& Blomhoff R. Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies. Am J Clin Nutr 2012;(1).
    PubMed
  77. Moller H, Sandin F, Robinson D, Bray F, Klint S, Linklater KM, Lambert PC, Pahlman L, Holmberg L, Morris E. Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. Eur J Cancer 2012; 48(1):46-53.
    PubMed
  78. Moore SC, Patel AV, Matthews CE, Berrington de GA, Park Y, Katki HA, Linet MS, Weiderpass E, Visvanathan K, Helzlsouer KJ, Thun M, Gapstur SM, Hartge P& Lee IM. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med 2012; 9(11):e1001335.
    PubMed
  79. Moritz V, Bretthauer M, Ruud HK, Glomsaker T, de LT, Sandvei P, Huppertz-Hauss G, Kjellevold O, Hoff G. Withdrawal time as a quality indicator for colonoscopy - a nationwide analysis. Endoscopy 2012; 44(5):476-481.
    PubMed
  80. Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Jr., Brown LM, Van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM. Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol 2012.
    PubMed
  81. Nagel G, Bjorge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Haggstrom C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). Br J Dermatol 2012.
    PubMed
  82. Nagel G, Stocks T, Spath D, Hjartaker A, Lindkvist B, Hallmans G, Jonsson H, Bjorge T, Manjer J, Haggstrom C, Engeland A, Ulmer H, Selmer R, Concin H, Stattin P& Schlenk RF. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol 2012; 91(10):1519-1531.
    PubMed
  83. Norum J, Hofvind S, Nieder C, Schnell EA, Broderstad AR. Mammographic screening in Sami speaking municipalities and a control group. Are early outcome measures influenced by ethnicity? Int J Circumpolar Health 2012; 71:1-6.
    PubMed
  84. Nygard M, Aagnes B, Bray F, Moller B, Mork J. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer 2012.
    PubMed
  85. Orem J, Sandin S, Weibull CE, Odida M, Wabinga H, Mbidde E, Wabwire-Mangen F, Meijer CJ, Middeldorp JM& Weiderpass E. Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Clin Epidemiol 2012.
    PubMed
  86. Olesen TB, Jensen KE, Nygard M, Tryggvadottir L, Sparen P, Hansen BT, Liaw KL, Kjaer SK. Young age at first intercourse and risk-taking behaviours--a study of nearly 65 000 women in four Nordic countries. Eur J Public Health 2012.
    PubMed
  87. Peplonska B, Bukowska A, Sobala W, Reszka E, Gromadzinska J, Wasowicz W, Lie JA, Kjuus H, Ursin G. Rotating night shift work and mammographic density. Cancer Epidemiol Biomarkers Prev 2012.
    PubMed
  88. Pukkala E, Helminen M, Haldorsen T, Hammar N, Kojo K, Linnersjo A, Rafnsson V, Tulinius H, Tveten U, Auvinen A. Cancer incidence among Nordic airline cabin crew. Int J Cancer 2012.
    PubMed
  89. Qureshi SA, Couto E, Hofvind S, Wu AH, Ursin G. Alcohol intake and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 2012; 131(3):993-1002.
    PubMed
  90. Qureshi SA, Ellingjord-Dale M, Hofvind S, Wu AH& Ursin G. Physical activity and mammographic density in a cohort of postmenopausal Norwegian women; a cross-sectional study. Springerplus 2012; 1(1):75.
    Springerplus
  91. Razavi P, Lee E, Bernstein L, Van Den Berg D, Horn-Ross PL, Ursin G. Variations in sex hormone metabolism genes, postmenopausal hormone therapy, and risk of endometrial cancer. Int J Cancer 2012; 130(7):1629-1638.
    PubMed
  92. Richiardi L, Corbin M, Marron M, Ahrens W, Pohlabeln H, Lagiou P, Minaki P, Agudo A, Castellsague X, Slamova A, Schejbalova M, Kjaerheim K, Barzan L, Talamini R, Macfarlane GJ, Macfarlane TV, Canova C, Simonato L, Conway DI, McKinney A, Sneddon L, Thomson P, Znoar A, Healy CM, McCartan BE, Benhamou S, Bouchardy C, Hashibe M, Brennan P, Merletti F. Occupation and risk of upper aerodigestive tract cancer: The ARCAGE study. Int J Cancer 2012; 130(10):2397-404.
    PubMed
  93. Rinaldi S, Lise M, Clavel-Chapelon F, Boutron-Ruault MC, Guillas G, Overvad K, Tjonneland A, Halkjaer J, Lukanova A, Kaaks R, Bergmann MM, Boeing H, Trichopoulou A, Zylis D, Valanou E, Palli D, Agnoli C, Tumino R, Polidoro S, Mattiello A, Bas Bueno-de-Mesquita H, Peeters PH, Weiderpass E, Lund E, Skeie G, Rodriguez L, Travier N, Sanchez MJ, Amiano P, Huerta JM, Ardanaz E, Rasmuson T, Hallmans G, Almquist M, Manjer J, Tsilidis KK, Allen NE, Khaw KT, Wareham N, Byrnes G, Romieu I, Riboli E, Franceschi S. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 2012.
    PubMed
  94. Riska A, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupation and risk of primary fallopian tube carcinoma in nordic countries. Int J Cancer 2012; 131(1):186-192.
    PubMed
  95. Robsahm TE, Bergva G, Hestvik UE& Moller B. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008. Melanoma Res 2012; 23(1):70-78.
    PubMed
  96. Rogne SG, Ronning P, Helseth E, Johannesen TB, Langberg CW, Lote K, Scheie D, Meling TR. Craniotomy for brain metastases: a consecutive series of 316 patients. Acta Neurol Scand 2012; 126(1):22-31.
    PubMed
  97. Ronning PA, Helseth E, Meling TR, Johannesen TB. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro Oncol 2012.
    PubMed
  98. Rostad H, Strom EH, Scott H, Ramnefjell M& Kjellevold K. Small Cell Lung Carcinoma: Better Than Its Reputation? A Population Based Study. J Interdiscipl Histopathol 2012; 1(1):1-4.
  99. Sagerup CM, Smastuen M, Johannesen TB, Helland A, Brustugun OT. Increasing Age and Carcinoma Not Otherwise Specified: A 20-Year Population Study of 40,118 Lung Cancer Patients. J Thorac Oncol 2012; 7(1):57-60.
    PubMed
  100. Sant M, Minicozzi P, Lagorio S, Johannesen TB, Marcos-Gragera R, Francisci S. Survival of european patients with central nervous system tumors. Int J Cancer 2012; 131(1):173-185.
    PubMed
  101. Schmidt M, Smastuen MC, Sondenaa K. Increased cancer incidence in some gallstone diseases, and equivocal effect of cholecystectomy: a long-term analysis of cancer and mortality. Scand J Gastroenterol 2012.
    PubMed
  102. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK. Association Between Prediagnostic IgE Levels and Risk of Glioma. J Natl Cancer Inst 2012.
    PubMed
  103. Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV, Jr., Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De V, I. Age at Last Birth in Relation to Risk of Endometrial Cancer: Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium. Am J Epidemiol 2012.
    PubMed
  104. Skaane P, Kshirsagar A, Hofvind S, Jahr G, Castellino RA. Mammography screening using independent double reading with consensus: Is there a potential benefit for computer-aided detection? Acta Radiol 2012.
    PubMed
  105. Solheim O, Jakola AS, Gulati S, Johannesen TB. Incidence and causes of perioperative mortality after primary surgery for intracranial tumors: a national, population-based study. J Neurosurg 2012; 116(4):825-834.
    PubMed
  106. Stang A, Martinsen JI, Kjaerheim K, Weiderpass E, Sparen P, Tryggvadottir L, Pukkala E. Cancer incidence among priests: 45 years of follow-up in four Nordic countries. Eur J Epidemiol 2012; 27(2):101-8.
    PubMed
  107. Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fossa SD, Lilleby W, Axcrona K, Smeland S. Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones. Prostate 2012; 72(6):668-76.
    PubMed
  108. Stensvold A, Dahl AA, Brennhovd B, Smastuen MC, Fossa SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S. Bother problems in prostate cancer patients after curative treatment. Urol Oncol 2012.
    PubMed
  109. Stocks T, Van HM, Manjer J, Bjorge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P. Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project. Hypertension 2012; 59(4):802-10.
    PubMed
  110. Strand TE, Bartnes K, Rostad H. National trends in lung cancer surgery. Eur J Cardiothorac Surg 2012.
    PubMed
  111. Syse A, Aas GB, Loge JH. Children and young adults with parents with cancer: a population-based study. Clin Epidemiol 2012; 4(1):41-52.
    PubMed
  112. Syse A, Tonnessen M. Cancer's unequal impact on incomes in Norway. Acta Oncol 2012; 51(4):480-489.
    PubMed
  113. Syse A, Lyngstad TH, Kravdal O. Does mortality after childhood cancer depend upon parents' social or economic resources? A population-based study. Int J Cancer 2012; 130(8):1870-1878.
    PubMed
  114. Syse A, Veenstra M, Aagnes B& Tretli S. Cancer incidence, prevalence and survival in an aging Norwegian population. Nor J Epidemiol 2012; 22(2):109-120.
  115. Talibov M, Kautiainen S, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupation and Leukemia in Nordic Countries. J Occup Environ Med 2012.
    PubMed
  116. Thorvaldsen TE, Nodtvedt AW, Grotmol T, Gunnes G. Morphological and immunohistochemical characterisation of seminomas in Norwegian dogs. Acta Vet Scand 2012; 54(1):52.
    PubMed
  117. Tjonnfjord GE, Jonsson V, Ly BE, Johannesen TB. Familial occurrence of chronic lymphocytic leukaemia in Norway. Tidsskr Nor Laegeforen 2012; 132(18):2060-2063.
    Doi:10.4045/tidsskr.11.1350
  118. Tjonnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jonsson V. Chronic lymphocytic leukaemia in Norway - incidence and prognostic markers at diagnosis. Tidsskr Nor Laegeforen 2012; 132(18):2056-2059.
    Doi:10.4045/tidsskr.11.1349
  119. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012; 23(2):363-370.
    PubMed
  120. Trocchi P, Ursin G, Kuss O, Ruschke K, Schmidt-Pokrzywniak A, Holzhausen HJ, Loning T, Thomssen C, Bocker W, Kluttig A& Stang A. Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities. BMC Cancer 2012; 12(1):554.
    PubMed
  121. Troisi R, Altantsetseg D, Davaasambuu G, Rich-Edwards J, Davaalkham D, Tretli S, Hoover RN, Frazier AL. Breast cancer incidence in Mongolia. Cancer Causes Control 2012; 23(7):1047-1053.
    PubMed
  122. Troisi R, Grotmol T, Jacobsen J, Tretli S, Toft-Sørensen H, Gissler M, Kaaja R, Potischman N, Ekbom A, Hoover RN& Stephansson O. Perinatal characteristics and breast cancer risk in daughters: A Scandinavian population-based study. Journal of Developmental Origins of Health and Disease 2012.
  123. Trope A, Sjoborg KD, Nygard M, Roysland K, Campbell S, Alfsen GC, Jonassen CM. Cytology and HPV testing 6-12 months after ASCUS/LSIL cytology in organised screening to predict high-grade cervical neoplasia between screening rounds. J Clin Microbiol 2012.
    PubMed
  124. Ulmer H, Bjorge T, Concin H, Lukanova A, Manjer J, Hallmans G, Borena W, Haggstrom C, Engeland A, Almquist M, Jonsson H, Selmer R, Stattin P, Tretli S, Kleiner A, Stocks T, Nagel G. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol 2012.
    PubMed
  125. Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernandez-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate MA, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim For The Uk Study Of Mri Screening, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le ML, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N et al. Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev 2012.
    PubMed
  126. Valberg M, Grotmol T, Tretli S, Veierod MB, Devesa SS, Aalen OO. Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years. Stat Med 2012.
    PubMed
  127. Valori R, Rey JF, Atkin WS, Bretthauer M, Senore C, Hoff G et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition - Quality assurance in endoscopy in colorectal cancer screening and diagnosis. Endoscopy 2012.
    Doi:10.1055/s-0032-1309795   
  128. van GW, van den Broek CB, Mroczkowski P, Dziki A, Romano G, Pavalkis D, Wouters MW, Moller B, Wibe A, Pahlman L, Harling H, Smith JJ, Penninckx F, Ortiz H, Valentini V, van de Velde CJ. The EURECCA project: Data items scored by European colorectal cancer audit registries. Eur J Surg Oncol 2012; 38(6):467-471.
    PubMed
  129. Weedon-Fekjaer H, Bakken K, Vatten LJ, Tretli S. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use. BMJ 2012; 344(7845):e299.
    PubMed
  130. Weiderpass E, Labreche F. Malignant tumors of the female reproductive system. Saf Health Work 2012; 3(3):166-180.
    PubMed
  131. Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S. Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 2012; 40(1):21-30.
    PubMed
  132. Woolcott CG, Koga K, Conroy SM, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I& Maskarinec G. Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies. Breast Cancer Res Treat 2012; 132(3):1163-1171.
    PubMed
  133. Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Ross JA, Schouten LJ, Shikany JM, Tsugane S, Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG, Smith-Warner SA. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 2012; 95(3):713-25.
    PubMed